160 related articles for article (PubMed ID: 26752990)
21. Novel Enhanced Therapeutic Efficacy of Dapoxetine HCl by Nano-Vesicle Transdermal Gel for Treatment of Carrageenan-Induced Rat Paw Edema.
Salem HF; Nafady MM; Kharshoum RM; Abd El-Ghafar OA; Farouk HO
AAPS PharmSciTech; 2020 Apr; 21(3):113. PubMed ID: 32291553
[TBL] [Abstract][Full Text] [Related]
22. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
Nugroho AK; Li GL; Danhof M; Bouwstra JA
Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
[TBL] [Abstract][Full Text] [Related]
23. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
24. Formulation Optimization and Ex Vivo and In Vivo Evaluation of Celecoxib Microemulsion-Based Gel for Transdermal Delivery.
Cao M; Ren L; Chen G
AAPS PharmSciTech; 2017 Aug; 18(6):1960-1971. PubMed ID: 27914040
[TBL] [Abstract][Full Text] [Related]
25. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
[TBL] [Abstract][Full Text] [Related]
26. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita KB; Banga AK
Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
[TBL] [Abstract][Full Text] [Related]
27. In vivo transungual iontophoresis: effect of DC current application on ionic transport and on transonychial water loss.
Dutet J; Delgado-Charro MB
J Control Release; 2009 Dec; 140(2):117-25. PubMed ID: 19709638
[TBL] [Abstract][Full Text] [Related]
28. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization.
Shamma RN; Elsayed I
J Liposome Res; 2013 Sep; 23(3):244-54. PubMed ID: 23713516
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of niosomal gel for iontophoresis mediated transdermal delivery of isosorbide dinitrate.
Jain S; Chaudhari BH; Swarnakar NK
Drug Deliv Transl Res; 2011 Aug; 1(4):309-21. PubMed ID: 25788365
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of a hydroxypropyl cellulose gel system for transdermal delivery of timolol.
Stamatialis DF; Rolevink HH; Gironès M; Nymeijer DC; Koops GH
Curr Drug Deliv; 2004 Oct; 1(4):313-9. PubMed ID: 16305393
[TBL] [Abstract][Full Text] [Related]
31. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
32. Iontophoretic delivery of lidocaine hydrochloride through
Manjunatha RG; Prasad R; Sharma S; Narayan RP; Koul V
J Dermatolog Treat; 2020 Mar; 31(2):191-199. PubMed ID: 30843444
[No Abstract] [Full Text] [Related]
33. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
34. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies.
Fang JY; Sung KC; Lin HH; Fang CL
Int J Pharm; 1999 Feb; 178(1):83-92. PubMed ID: 10205628
[TBL] [Abstract][Full Text] [Related]
35. Novel iontophoretic drug delivery of estradiol with alendronate for osteoporosis treatment.
Li S; Chang J
Pak J Pharm Sci; 2023 Mar; 36(2):541-546. PubMed ID: 37530163
[TBL] [Abstract][Full Text] [Related]
36. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, anti-inflammatory activity and skin irritation tests.
Soliman SM; Abdel Malak NS; El-Gazayerly ON; Abdel Rehim AA
Drug Discov Ther; 2010 Dec; 4(6):459-71. PubMed ID: 22491312
[TBL] [Abstract][Full Text] [Related]
37. Improvement on conventional constant current DC iontophoresis: a study using constant conductance AC iontophoresis.
Zhu H; Li SK; Peck KD; Miller DJ; Higuchi WI
J Control Release; 2002 Aug; 82(2-3):249-61. PubMed ID: 12175741
[TBL] [Abstract][Full Text] [Related]
38. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
39. Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations.
Shamsher AA; Charoo NA; Rahman Z; Pillai KK; Kohli K
Pharm Dev Technol; 2014 Feb; 19(1):21-30. PubMed ID: 23281713
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
Yan G; Li SK; Higuchi WI
J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
